MSU Drug Discovery
Display Accessibility
Tools
Accessibility Tools
Grayscale
Highlight Links
Change Contrast
Increase Text Size
Increase Letter Spacing
Dyslexia Friendly Font
Increase Cursor Size
.png){kind=small}
.png)
Sept. 27, 2022
Dr. Karen Draths - "New Pathways for Commodity Chemical Synthesis from Carbon Dioxide and Methane"
Sept. 20, 2022
Dr. Ruben MLC Biancatelli - "Novel therapeutic interventions for Lung Injury"
Sept. 13, 2022
May 13
, 2022
Dr. Bruce Bloom - "Academic Drug Re-purposing: Perspectives From Industry And Philanthropy"
April
2022
Gallo Lab Publication
BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors
March 11, 2022
MSU DD News
Joint MSU/UofM IP acquired by OncoArendi Therapeutics
January 7, 2022
Liby Lab Publication
"The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer"
Spring 2022
.png)
